These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15070133)

  • 21. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma.
    Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER
    Hum Mol Genet; 1994 Feb; 3(2):347-50. PubMed ID: 8004107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
    Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
    J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schwannoma invading the cochlea in a neurofibromatosis type 2 patient.
    Abelak YR; Linthicum FH
    Otol Neurotol; 2007 Feb; 28(2):284-5. PubMed ID: 17159490
    [No Abstract]   [Full Text] [Related]  

  • 24. Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2.
    Baser ME; Mautner VF; Parry DM; Evans DG
    J Med Genet; 2005 Dec; 42(12):903-6. PubMed ID: 15831594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiosurgery in NF2.
    Matsuno A; Nagashima T
    J Neurosurg; 1999 Oct; 91(4):714-5. PubMed ID: 10507400
    [No Abstract]   [Full Text] [Related]  

  • 26. Somatic neurofibromatosis type 2 gene mutations and growth characteristics in vestibular schwannoma.
    Irving RM; Harada T; Moffat DA; Hardy DG; Whittaker JL; Xuereb JH; Maher ER
    Am J Otol; 1997 Nov; 18(6):754-60. PubMed ID: 9391673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas.
    Mohyuddin A; Neary WJ; Wallace A; Wu CL; Purcell S; Reid H; Ramsden RT; Read A; Black G; Evans DG
    J Med Genet; 2002 May; 39(5):315-22. PubMed ID: 12011146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurofibromatosis type 2.
    Sathornsumetee S; DesJardins A; Reardon DA; Rich JN; Vredenburgh JJ
    Neurology; 2007 Mar; 68(13):E14. PubMed ID: 17389295
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neurotrophic factor expression in vestibular schwannoma. An overview].
    Diensthuber M; Lenarz T; Stöver T
    Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.
    Bonne N-; Aboukais R; Baroncini M; Hochart A; Leblond P; Broly F; Dubrulle F; Lejeune JP; Vincent C
    Childs Nerv Syst; 2016 Dec; 32(12):2403-2413. PubMed ID: 27704245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acustic neurinoma: correlation between clinic and MRI].
    Conforti R; Faella P; Sica A; Landi N; Faggian A; Amato M; Raucci A; Scuotto A
    Recenti Prog Med; 2013; 104(7-8):299-302. PubMed ID: 24042396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
    Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
    Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of alleles in vestibular schwannomas: use of microsatellite markers on chromosome 22.
    Sainz J; Baser ME; Ragge NK; Nelson RA; Pulst SM
    Arch Otolaryngol Head Neck Surg; 1993 Dec; 119(12):1285-8. PubMed ID: 17431981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.
    Zhao F; Wang B; Yang Z; Zhou Q; Li P; Wang X; Zhang J; Zhang J; Liu P
    J Neurooncol; 2018 Jun; 138(2):417-424. PubMed ID: 29492767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
    Welling DB
    Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Selected problems of neurofibromatosis with presentation of a case of multiple intracranial and intramedullary tumors].
    Stachura Z; Zralek C; Siemianowicz S; Kiczka-Zralek M; Zawadzki T; Kluczewska E; Giec-Lorenc A
    Neurol Neurochir Pol; 1998; 32(6):1563-9. PubMed ID: 10358844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations.
    Mahboubi H; Maducdoc MM; Yau AY; Ziai K; Ghavami Y; Badran KW; Al-Thobaiti M; Brandon B; Djalilian HR
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):822-31. PubMed ID: 25791708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
    Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
    Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic Severity Score predicts clinical phenotype in NF2.
    Halliday D; Emmanouil B; Pretorius P; MacKeith S; Painter S; Tomkins H; Evans DG; Parry A
    J Med Genet; 2017 Oct; 54(10):657-664. PubMed ID: 28848060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.